Display Settings:

Format

Send to:

Choose Destination
    Int Rev Immunol. 2009;28(6):465-86.

    Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis.

    Source

    ActoGeniX N.V., Zwijnaarde, Belgium. Pieter.Rottiers@ActoGeniX.com

    Abstract

    Lactic acid bacteria are a group of taxonomically diverse, Gram-positive food-grade bacteria that have been safely consumed throughout history. The lactic acid bacterium Lactococcus lactis, well-known for its use in the manufacture of cheese, can be genetically engineered and orally formulated to deliver therapeutic proteins in the gastrointestinal tract. This review focuses on the genetic engineering of Lactococcus lactis to secrete high-quality, correctly processed bioactive molecules derived from a eukaryotic background. The therapeutic applications of these genetically modified strains are discussed, with special regards to immunomodulation.

    PMID:
    19954359
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk